Neuroprotective Effects of Fingolimod in a Cellular Model of Optic Neuritis
Visual dysfunction resulting from optic neuritis (ON) is one of the most common clinical manifestations of multiple sclerosis (MS), characterized by loss of retinal ganglion cells, thinning of the nerve fiber layer, and inflammation to the optic nerve. Current treatments available for ON or MS are o...
Guardado en:
Autores principales: | Amritha A. Candadai, Fang Liu, Arti Verma, Mir S. Adil, Moaddey Alfarhan, Susan C. Fagan, Payaningal R. Somanath, S. Priya Narayanan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/84d2577ff1f94fce89aef8faa6029b1e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis
por: Jagadeswara Rao Earla, et al.
Publicado: (2021) -
Neuritis óptica en niños: Experiencia clínica en 13 años
por: Siebert V,Alejandra, et al.
Publicado: (2009) -
Comparison of the Structure and Function of the Retina and the Optic Nerve in Patients with a History of Multiple Sclerosis-Related Demyelinating Retrobulbar Optic Neuritis Treated and Not Treated with Systemic Steroid Therapy
por: Nowacka B, et al.
Publicado: (2021) -
Retinal nerve fiber layer thickness in multiple sclerosis with and without optic neuritis: a four-year follow-up study from Oman
por: Abdullah S. Al-Mujaini, et al.
Publicado: (2021) -
Long-term structural retinal changes in patients with optic neuritis related to multiple sclerosis
por: Andersen MR, et al.
Publicado: (2017)